Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT00653757
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Pathologically confirmed prostate cancer
* Stage I-IV disease (T1-4, N0-1, M0)
* No evidence of distant metastases (M0) on physical examination or bone scan
PATIENT CHARACTERISTICS:
* ECOG performance status 0-2
* Hemoglobin ≥ 10.0 g/dL
* WBC ≥ 3,000/mcL
* Platelet count ≥ 90,000/mm
* AST \< 2 times the upper limit of normal
* No allergy to leuprolide acetate or goserelin
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
19 Years
Study:
NCT00653757
Study Brief:
Protocol Section:
NCT00653757